Active vitamin d and acute respiratory infections in dialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 6, 2011, Pages 1361-1367

  Tsujimoto, Yoshihiro ^a   Tahara, Hideki ^b   Shoji, Tetsuo ^b   Emoto, Masanori ^b   Koyama, Hidenori ^b   Ishimura, Eiji ^b   Tabata, Tsutomu ^a   Nishizawa, Yoshiki ^c   Inaba, Masaaki ^b  

^a Inoue Eye Hospital   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Osaka Prefecture University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; VITAMIN D RECEPTOR ACTIVATOR;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; JAPANESE; LUNG MYCOSIS; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; TREATMENT OUTCOME; VIRUS PNEUMONIA;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; CALCITRIOL; CHI-SQUARE DISTRIBUTION; DIETARY SUPPLEMENTS; DISEASE-FREE SURVIVAL; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYCHOLECALCIFEROLS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CALCITRIOL; RENAL DIALYSIS; RESPIRATORY TRACT INFECTIONS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VITAMINS;

EID: 79958260423     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08871010     Document Type: Article

References (53)

1. Veldman CM, Cantorna MT, DeLuca HF: Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. ArchBiochem Biophys 374: 334-338, 2000.
2. Holick MF: Vitamin D: Importance in the prevention of cancers,type 1 diabetes, heart disease, and osteoporosis. Am JClin Nutr 79: 362-371, 2004.
3. Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D: Antiproteinuric effect of oralparicalcitol in chronic kidney disease. Kidney Int 68: 2823-2828, 2005.
4. Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, Doi T:A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis.Am J Pathol 158: 1733-1741, 2001.
5. Zittermann A, Koerfer R: Protective and toxic effects of vitaminD on vascular calcification: Clinical implications. MolAspects Med 29: 423-432, 2008.
6. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK: Intravenous calcitriol regresses myocardialhypertrophy in hemodialysis patients with secondaryhyperparathyroidism. Am J Kidney Dis 33: 73-81, 1999.
7. Pfeifer M, Begerow B, Minne HW, Nachtigall D, Hansen C: Effects of a short-term vitamin D(3) and calcium supplementationon blood pressure and parathyroid hormone levels inelderly women. J Clin Endocrinol Metab 86: 1633-1637,2001.
8. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG; Iowa Women's Health Study: Vitamin D intake is inverselyassociated with rheumatoid arthritis: Results from theIowa Women's Health Study. Arthritis Rheum 50: 72-77,2004.
9. Gysemans CA, Cardozo AK, Callewaert H, Giulietti A, Hulshagen L, Bouillon R, Eizirik DL, Mathieu C: 1,25-DihydroxyvitaminD3 modulates expression of chemokines andcytokines in pancreatic islets: Implications for prevention ofdiabetes in nonobese diabetic mice. Endocrinology 146:1956-1964, 2005.
10. Ginde AA, Mansbach JM, Camargo CA Jr: Association betweenserum 25-hydroxyvitamin D level and upper respiratorytract infection in the Third National Health and NutritionExamination Survey. Arch Intern Med 169: 384-390, 2009.
11. Laaksi I, Ruohola JP, Tuohimaa P, Auvinen A, Haataja R, Pihlajamaki H, Ylikomi T: An association of serum vitamin Dconcentrations _ 40 nmol/L with acute respiratory tract infectionin young Finnish men. Am J Clin Nutr 86: 714-717,2007.
12. Wayse V, Yousafzai A, Mogale K, Filteau S: Association ofsubclinical vitamin D deficiency with severe acute lower respiratoryinfection in Indian children under 5 y. Eur J ClinNutr 58: 563-567, 2004.
13. Karatekin G, Kaya A, Salihoglu O, Balci H, Nuhoglu A: Associationof subclinical vitamin D deficiency in newborns withacute lower respiratory infection and their mothers. Eur J ClinNutr 63: 473-477, 2009.
14. Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H: Serumlevels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitaminD, and 25-hydroxyvitamin D in nondialyzed patientswith chronic renal failure. Kidney Int 55: 1019-1027, 1999.
15. Bhan I, Burnett-Bowie SA, Ye J, Tonelli M, Thadhani R: Clinicalmeasures identify vitamin D deficiency in dialysis. ClinJ Am Soc Nephrol 5: 460-467, 2010.
16. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y: Lower risk for cardiovascular mortality in oral1alpha-hydroxy vitamin D3 users in a haemodialysis population.Nephrol Dial Transplant 19: 179-184, 2004.
17. Naves-Díaz M, Alvarez-Hernandez D, Passlick-Deetjen J, Guinsburg A, Marelli C, Rodriguez-Puyol D, Cannata-Andía JB: Oral active vitamin D is associated with improved survivalin hemodialysis patients. Kidney Int 74: 1070-1078,2008.
18. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, CamargoCA Jr, Thadhani R: Activated injectable vitamin D andhemodialysis survival: A historical cohort study. J Am SocNephrol 16: 1115-1125, 2005.
19. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicatorsof bone disease in maintenance hemodialysis patients.Kidney Int 70: 771-780, 2006.
20. St. Peter WL, Li S, Liu J, Gilbertson DT, Arneson TJ, Collins AJ: Effects of monthly dose and regular dosing of intravenousactive vitamin D use on mortality among patients undergoinghemodialysis. Pharmacotherapy 29: 154-164, 2009.
21. Tentori F, Albert JM, Young EW, Blayney MJ, Robinson BM, Pisoni RL, Akiba T, Greenwood RN, Kimata N, Levin NW, Piera LM, Saran R, Wolfe RA, Port FK: The survival advantagefor haemodialysis patients taking vitamin D is questioned:Findings from the Dialysis Outcomes and PracticePatterns Study. Nephrol Dial Transplant 24: 963-972, 2009.
22. Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG: Mortality risk among hemodialysispatients receiving different vitamin D analogs.Kidney Int 70: 1858-1865, 2006.
23. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K: Association of activated vitamin D treatment and mortality inchronic kidney disease. Arch Intern Med 168: 397-403,2008.
24. Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B: Association of oral calcitriol with improved survival in nondialyzedCKD. J Am Soc Nephrol 19: 1613-1619, 2008.
25. U.S. Renal Data System: 2009 Annual Data Report: Atlas ofChronic Kidney Disease and End-Stage Renal Disease in theUnited States, Bethesda, MD, National Institutes of Health,National Institute of Diabetes and Digestive and Kidney Disease,2009.
26. Sarnak MJ, Jaber BL: Pulmonary infectious mortality amongpatients with end-stage renal disease. Chest 120: 1883-1887,2001.
27. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W: Septicemiain dialysis patients: Incidence, risk factors, and prognosis.Kidney Int 55: 1081-1090, 1999.
28. Hoen B, Paul-Dauphin A, Hestin D, Kessler M: A multicenterprospective study of risk factors for bacteremia in chronichemodialysis patients. J Am Soc Nephrol 9: 869-876, 1998.
29. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, Tranaeus A, Stenvinkel P, Lindholm B: Aspects ofimmune dysfunction in end-stage renal disease. Clin J AmSoc Nephrol 3: 1526-1533, 2008.
30. Vanholder R, Van Loo A, Dhondt AM, De Smet R, Ringoir S: Influence of uraemia and haemodialysis on host defence andinfection. Nephrol Dial Transplant 11: 593-598, 1996.
31. Hauser AB, Stinghen AE, Kato S, Bucharles S, Aita C, Yuzawa Y, Pecoits-Filho R: Characteristics and causes of immune dysfunctionrelated to uremia and dialysis. Perit Dial Int28[Suppl 3]: S183-S187, 2008.
32. Dalrymple LS, Go AS: Epidemiology of acute infectionsamong patients with chronic kidney disease. Clin J Am SocNephrol 3: 1487-1493, 2008.
33. Allon M, Depner TA, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ; HEMO Study Group: Impact of dialysis doseand membrane on infection-related hospitalization anddeath: Results of the HEMO Study. J Am Soc Nephrol 14:1863-1870, 2003.
34. Pastan S, Soucie JM, McClellan WM: Vascular access andincreased risk of death among hemodialysis patients. KidneyInt 62: 620-626, 2002.
35. Linday LA, Shindledecker RD, Tapia-Mendoza J, Dolitsky JN: Effect of daily cod liver oil and a multivitamin-mineral supplementwith selenium on upper respiratory tract pediatricvisits by young, inner-city, Latino children: Randomized pediatricsites. Ann Otol Rhinol Laryngol 113: 891-901, 2004.
36. Rehman PK: Sub-clinical rickets and recurrent infection. JTrop Pediatr 40: 58, 1994.
37. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H: Randomized trial of vitamin D supplementation toprevent seasonal influenza A in schoolchildren. Am J ClinNutr 91: 1255-1260, 2010.
38. Li-Ng M, Aloia JF, Pollack S, Cunha BA, Mikhail M, Yeh J, Berbari N: A randomized controlled trial of vitamin D3 supplementationfor the prevention of symptomatic upper respiratorytract infections. Epidemiol Infect 137: 1396-1404,2009.
39. Avenell A, Cook JA, Maclennan GS, Macpherson GC: VitaminD supplementation to prevent infections: A sub-study ofa randomised placebo-controlled trial in older people. AgeAgeing 36: 574-577, 2007.
40. Inaguma D, Nagaya H, Hara K, Tatematsu M, Shinjo H, Suzuki S, Mishima T, Kurata K: Relationship between serum1,25-dihydroxyvitamin D and mortality in patients with predialysischronic kidney disease. Clin Exp Nephrol 12: 126-131, 2008.
41. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C: Vitamin D levels and patientoutcome in chronic kidney disease. Kidney Int 75: 88-95,2009.
42. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, Choukroun G, Fournier A, Massy ZA: Vitamin D affects survivalindependently of vascular calcification in chronic kidneydisease. Clin J Am Soc Nephrol 4: 1128-1135, 2009.
43. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC: Chronic kidneydisease, hypovitaminosis D, and mortality in the UnitedStates. Kidney Int 76: 977-983, 2009.
44. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysispatients. Kidney Int 72: 1004-1013, 2007.
45. Matias PJ, Ferreira C, Jorge C, Borges M, Aires I, Amaral T, Gil C, Cortez J, Ferreira A: 25-Hydroxyvitamin D3, arterialcalcifications and cardiovascular risk markers in haemodialysispatients. Nephrol Dial Transplant 24: 611-618, 2009.
46. Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, Sea MM, Woo J: Serum 25-hydroxyvitamin D status and cardiovascularoutcomes in chronic peritoneal dialysis patients:A 3-y prospective cohort study. Am J Clin Nutr 87: 1631-1638, 2008.
47. Tabata T, Shoji T, Kikunami K, Matsushita Y, Inoue T, Tanaka S, Hino M, Miki T, Nishizawa Y, Morii H: In vivo effect of 1alpha-hydroxyvitamin D3 on interleukin-2 production in hemodialysispatients. Nephron 50: 295-298, 1988.
48. Panichi V, De Pietro S, Andreini B, Bianchi AM, Migliori M, Taccola D, Giovannini L, Tetta C, Palla R: Calcitriol modulatesin vivo and in vitro cytokine production: A role for intracellularcalcium. Kidney Int 54: 1463-1469, 1998.
49. Cohen ML, Douvdevani A, Chaimovitz C, Shany S: Regulationof TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in humanmacrophages from CAPD patients. Kidney Int 59: 69-75, 2001.
50. Tabata T, Suzuki R, Kikunami K, Matsushita Y, Inoue T, Inoue T, Okamoto T, Miki T, Nishizawa Y, Morii H: The effectof 1 alpha-hydroxyvitamin D3 on cell-mediated immunity inhemodialyzed patients. J Clin Endocrinol Metab 63: 1218-1221, 1986.
51. Alpdogan O, Ozgun S, Lawrence R, Ozener C, Akoglu E, Akoglu T: The effect of 1,25 dihydroxyvitamin D3 on lymphocytetransformation in patients with chronic renal failure.Intern Med 34: 240-242, 1995.
52. Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA Jr, Koeffler HP, Thadhani R: Low plasma level of cathelicidinantimicrobial peptide (hCAP18) predicts increased infectiousdisease mortality in patients undergoing hemodialysis. ClinInfect Dis 48: 418-424, 2009.
53. Dukkipati R, Kovesdy CP, Colman S, Budoff MJ, Nissenson ARAssociation ofrelatively low serum parathyroid hormone with malnutritioninflammationcomplex and survival in maintenance hemodialysispatients. J Ren Nutr 20: 243-254, 2010